Table 1.
Demographic data | |
---|---|
Age (years) | 57.8 ± 8.6 |
Gender (male) | 456 (62.9) |
Estimated duration of diabetes (years) | 9.9 ± 7.2 |
Body mass index (kg/m2) | 24.6 ± 4.1 |
HbA1c (%) | 7.0 ± 1.0 |
Fasting blood glucose (mg/dl) | 134 ± 31 |
Systolic blood pressure (mmHg) | 127 ± 14 |
Diastolic blood pressure (mmHg) | 77 ± 11 |
Total cholesterol (mg/dL) | 185 ± 28 |
High-density lipoprotein-cholesterol (mg/dL) | 59 ± 14 |
Triglyceride (mg/dL) | 100 [70, 152] |
Aspartate aminotransferase (U/L) | 21 [18, 27] |
Alanine aminotransferase (U/L) | 22 [16, 33] |
γ-glutamyl transpeptidase (U/L) | 25 [17, 39] |
Uric Acid (mg/dl) | 5.5 ± 1.2 |
Estimated glomerular filtration rate (ml/min/ 1.73 m2) | 78 ± 18 |
Urinary albumin excretion (mg/g creatinine) | 10 [6, 23] |
brachial-ankle pulse wave velocity (cm/s) | 1543 ± 279 |
Morningness-Eveningness Questionnaire | 57.4 ± 7.3 |
Pittsburg Sleep Quality Index | 5.1 ± 3.0 |
Beck Depression inventory -II | 9.9 ± 7.6 |
Energy intake (kcal/day) | 1713 ± 582 |
Physical activity (Mets/h/week) | 42.8 ± 70.5 |
Sleep duration (hours) | 6.4 ± 1.2 |
Current smoker (yes) | 174 (24.0) |
Alcohol (g/day) | 12.3 ± 21.5 |
Treatment modality (n/%) | |
Diabetes medication (yes) | 620 (85.5) |
Hypertension medication (yes) | 346 (47.7) |
Hyperlipidemia medication (yes) | 442 (61.0) |
Data are mean ± SD or number (percentage) of patients